FDA Clearance Tracker · K180559
HSV 1 & 2 ELITe MGB Kit; ELITe InGenius
Last checked: Nov 20, 2026Latest source record: Oct 29, 2018 (this decision)Source: openFDAMethods & limitations
Decided
Oct 29, 2018
Substantially Equivalent
Time to decision
242 days
Received Mar 1, 2018. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K180559
- Device name
- HSV 1 & 2 ELITe MGB Kit; ELITe InGenius
- Applicant
- Elitechgroup
- Applicant location
- Bothell, WA
- Received
- Mar 1, 2018
- Decided
- Oct 29, 2018
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 866.3309
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code PGI. The earliest in FDA's data is DEN140004, decided May 13, 2014.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K180559
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Elitechgroup
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K180627 · Decided Jul 27, 2018 · 140 days after receipt
Device type: Device, Iontophoresis, Specific Uses (KTB) · Physical Medicine & Rehabilitation
K171401 · Decided Jul 11, 2017 · 60 days after receipt
Device type: Diazo Colorimetry, Bilirubin (CIG) · Laboratory Medicine & Pathology
K153644 · Decided Sep 7, 2016 · 261 days after receipt
Device type: Hexokinase, Glucose (CFR) · Laboratory Medicine & Pathology
2 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.